Professor Nathan Karin of the Rappaport faculty of Medicine at Israel’s Technion Institute invented an antibody that activates cells in the immune system, thereby reducing inflammation. After years of development, Pfizer has now signed an agreement to commercialize the product.
http://www.globes.co.il/en/article-pfizer-buys-rights-to-biorap-autoimmune-drug-1001128916